anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Title

Component collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 303,780
Current window 222,841-222,870
Pages 10,126
Rows per page 30
Component: Titleclear collectionreset all
18 30 60

Component

222,841-222,870 of 303,780

filter-aware
03
Alkermes | Results Presentation Deck | 27 slidesAlkermes | Results Presentation Deck | 27 slides · Alkermes
Conference presentation Investor relations Beat · Problem1 hit
04
The slide highlights significant growth in revenue and net income metrics year-over-year.Alkermes | Results Presentation Deck | 27 slides · Alkermes
Conference presentation Investor relations Beat · Problem1 hit
05
Includes a blue box highlight around the Q3'23 column.Alkermes | Results Presentation Deck | 27 slides · Alkermes
Conference presentation Investor relations 1 hit
06
Includes both GAAP and non-GAAP projections, plus specific product revenue breakdowns.Alkermes | Results Presentation Deck | 27 slides · Alkermes
Conference presentation Investor relations 1 hit
07
Alkermes | Results Presentation Deck | 27 slidesAlkermes | Results Presentation Deck | 27 slides · Alkermes
Conference presentation Investor relations Beat · Solution1 hit
08
The chart illustrates the revenue contribution of four specific products (VIVITROL, ARISTADA, VUMERITY, LYBALVI) over time.Alkermes | Results Presentation Deck | 27 slides · Alkermes
Conference presentation Investor relations Beat · Solution1 hit
09
Includes a disclaimer regarding the forward-looking nature of the expectations.Alkermes | Results Presentation Deck | 27 slides · Alkermes
Conference presentation Investor relations Beat · Solution1 hit
10
The chart tracks TRx (Total Prescriptions) over 101 weeks.Alkermes | Results Presentation Deck | 27 slides · Alkermes
Conference presentation Investor relations Beat · Solution1 hit
11
Alkermes | Results Presentation Deck | 27 slidesAlkermes | Results Presentation Deck | 27 slides · Alkermes
Conference presentation Investor relations Beat · Solution1 hit
12
Alkermes | Results Presentation Deck | 27 slidesAlkermes | Results Presentation Deck | 27 slides · Alkermes
Conference presentation Investor relations Beat · Solution1 hit
13
Alkermes | Results Presentation Deck | 27 slidesAlkermes | Results Presentation Deck | 27 slides · Alkermes
Conference presentation Investor relations Beat · Market Size1 hit
14
Alkermes | Results Presentation Deck | 27 slidesAlkermes | Results Presentation Deck | 27 slides · Alkermes
Conference presentation Investor relations Beat · Market Size1 hit
15
The slide illustrates the escalation of doses for both SAD and MAD study arms.Alkermes | Results Presentation Deck | 27 slides · Alkermes
Conference presentation Investor relations Beat · Market Size1 hit
16
SAD: Single Ascending Dose; MAD: Multiple Ascending Dose; AE: Adverse Event; SAE: Serious Adverse Event.Alkermes | Results Presentation Deck | 27 slides · Alkermes
Conference presentation Investor relations Beat · Market Size1 hit
17
Includes box plots for AUC and Cmax across dose levels (1, 3, 8, 15, 25, 50 mg).Alkermes | Results Presentation Deck | 27 slides · Alkermes
Conference presentation Investor relations Beat · Market Size1 hit
18
The diagram illustrates a 4-way cross-over design with 4 patients, each receiving a different sequence of placebo and three dose levels (1mg, 3mg, 8mg).Alkermes | Results Presentation Deck | 27 slides · Alkermes
Conference presentation Investor relations Beat · Market Size1 hit
19
The slide presents clinical trial baseline data for a very small sample size (N=4).Alkermes | Results Presentation Deck | 27 slides · Alkermes
Conference presentation Investor relations Beat · Market Size1 hit
20
The table displays n (%) for adverse events related to the study drug.Alkermes | Results Presentation Deck | 27 slides · Alkermes
Conference presentation Investor relations Beat · Market Size1 hit
21
Data represents NT1 patients; N=4 per dose; P-values indicate statistical significance vs placebo.Alkermes | Results Presentation Deck | 27 slides · Alkermes
Conference presentation Investor relations Beat · Market Size1 hit
22
The chart uses a split x-axis to show pre-dose baseline and post-dose results. The 8mg dose maintains maximum sleep latency (40 min) for the duration of the test.Alkermes | Results Presentation Deck | 27 slides · Alkermes
Conference presentation Investor relations Beat · Market Size1 hit
23
Alkermes | Results Presentation Deck | 27 slidesAlkermes | Results Presentation Deck | 27 slides · Alkermes
Conference presentation Investor relations Beat · Market Size1 hit
24
Alkermes | Results Presentation Deck | 27 slidesAlkermes | Results Presentation Deck | 27 slides · Alkermes
Conference presentation Investor relations Beat · Financials1 hit
25
Alkermes | Results Presentation Deck | 27 slidesAlkermes | Results Presentation Deck | 27 slides · Alkermes
Conference presentation Investor relations Beat · Financials1 hit
26
Includes specific line items for share-based compensation, depreciation, amortization, separation expense, tax effects, non-cash interest, and a Janssen arbitration award.Alkermes | Results Presentation Deck | 27 slides · Alkermes
Conference presentation Investor relations Beat · Financials1 hit
01
Slide 1
Amazon | Results Presentation Deck | 19 slidesAmazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · What Is1 hit
03
The slide includes a footnote explaining the F/X adjusted metric.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · What Is1 hit
04
The slide uses a bar chart for time-series growth and a pie chart for segment composition.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · What Is1 hit
05
The chart includes a callout box emphasizing the year-over-year growth percentage.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · What Is1 hit
06
The chart includes a callout bubble emphasizing the growth rate.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · What Is1 hit
07
Includes a footnote explaining the impact of Rivian Automotive investment valuation gains on net income.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · What Is1 hit